These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14699909)

  • 1. Additive effect of midazolam and progesterone on the EEG in rats.
    Hoyo-Vadillo C; López-Trujillo E; Venturelli CR
    Proc West Pharmacol Soc; 2003; 46():132-3. PubMed ID: 14699909
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat.
    Bol CJ; Vogelaar JP; Tang JP; Mandema JW
    J Pharmacol Exp Ther; 2000 Jul; 294(1):347-55. PubMed ID: 10871332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam.
    Tuk B; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):202-7. PubMed ID: 9435179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam.
    Tuk B; van Oostenbruggen MF; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1999 May; 289(2):1067-74. PubMed ID: 10215689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 7-day exposure to midazolam on electroencephalogram pharmacodynamics in rats: a model to study multiple pharmacokinetic-pharmacodynamic relationships in individual animals.
    Laurijssens BE; Greenblatt DJ
    J Pharm Pharmacol; 2002 Jan; 54(1):77-86. PubMed ID: 11829133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of extremely low doses of phenazepam on EEG of rats and their behavior in various models of anxiety].
    Voronina TA; Molodavkin GM; Cherniavskaia LI; Seredenin SB; Burlakova EB
    Biull Eksp Biol Med; 1997 Sep; 124(9):308-10. PubMed ID: 9445614
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats.
    Visser SA; Huntjens DR; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):765-75. PubMed ID: 12975494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.
    Cleton A; Mazee D; Voskuyl RA; Danhof M
    Br J Pharmacol; 1999 May; 127(1):227-35. PubMed ID: 10369477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midazolam suppresses spike-and-wave rhythm accompanying three different models of epileptic seizures.
    Kubová H; Mocková M; Mares P
    Physiol Res; 1999; 48(6):491-500. PubMed ID: 10783915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.
    Hotz MA; Ritz R; Linder L; Scollo-Lavizzari G; Haefeli WE
    Br J Clin Pharmacol; 2000 Jan; 49(1):72-9. PubMed ID: 10606840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze.
    Stern CA; Carobrez AP; Bertoglio LJ
    Pharmacol Biochem Behav; 2008 Oct; 90(4):545-50. PubMed ID: 18533241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo.
    Hoyo-Vadillo C; Mandema JW; Danhof M
    Life Sci; 1995; 57(4):325-33. PubMed ID: 7603305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of midazolam on the expression of conditioned taste aversion in rats.
    Yasoshima Y; Yamamoto T
    Brain Res; 2005 May; 1043(1-2):115-23. PubMed ID: 15862524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute interactive effects of estradiol and benzodiazepines on the central nervous system.
    Hoyo-Vadillo C; Pluma N; Ramírez EB; Escobar E; Venturelli CR
    Proc West Pharmacol Soc; 2005; 48():59-60. PubMed ID: 16416662
    [No Abstract]   [Full Text] [Related]  

  • 16. Midazolam-induced extrapyramidal side effects.
    Prommer EE
    J Pain Symptom Manage; 2008 Nov; 36(5):e5-6. PubMed ID: 18752923
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous midazolam as a cause of extrapyramidal side effects in a patient with prostate cancer.
    Brown DJ; McArthur D; Moulsdale H
    J Pain Symptom Manage; 2007 Aug; 34(2):111-3. PubMed ID: 17604593
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
    Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
    Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.